151 related articles for article (PubMed ID: 2049254)
1. A method for bioassay of potency and effectiveness of inhaled bronchodilators in normal subjects.
Foster RW; Atanga GK; Carpenter JR; Evans DE; Rakshi K; Small RC
Br J Clin Pharmacol; 1991 Apr; 31(4):445-55. PubMed ID: 2049254
[TBL] [Abstract][Full Text] [Related]
2. Effects of nebulised magnesium sulphate on inflammation and function of the guinea-pig airway.
Turner DL; Ford WR; Kidd EJ; Broadley KJ; Powell C
Eur J Pharmacol; 2017 Apr; 801():79-85. PubMed ID: 28284753
[TBL] [Abstract][Full Text] [Related]
3. Metaproterenol responsiveness after methacholine- and histamine-induced bronchoconstriction.
Elsasser S; Donna E; Demirozu CM; Danta I; Wanner A
Chest; 1996 Sep; 110(3):617-23. PubMed ID: 8797401
[TBL] [Abstract][Full Text] [Related]
4. Effect of reproterol either alone or combined with disodium cromoglycate on airway responsiveness to methacholine.
Kanniess F; Jörres RA; Magnussen H
Pulm Pharmacol Ther; 2005; 18(5):315-20. PubMed ID: 15939309
[TBL] [Abstract][Full Text] [Related]
5. Effect of prior bronchoconstriction on the airway response to histamine in normal subjects.
Chung KF; Snashall PD
Thorax; 1984 Jan; 39(1):40-5. PubMed ID: 6364444
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ
Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705
[TBL] [Abstract][Full Text] [Related]
7. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
[TBL] [Abstract][Full Text] [Related]
8. Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline.
Cushley MJ; Tattersfield AE; Holgate ST
Am Rev Respir Dis; 1984 Mar; 129(3):380-4. PubMed ID: 6703496
[TBL] [Abstract][Full Text] [Related]
9. TPI 1020, a novel anti-inflammatory, nitric oxide donating compound, potentiates the bronchodilator effects of salbutamol in conscious guinea-pigs.
Turner DL; Ferrari N; Ford WR; Kidd EJ; Paquet L; Renzi P; Broadley KJ
Eur J Pharmacol; 2010 Sep; 641(2-3):213-9. PubMed ID: 20639142
[TBL] [Abstract][Full Text] [Related]
10. An in vitro bioassay for evaluating the effect of inhaled bronchodilators on airway smooth muscle.
Muddle J; Kanabar V; Brown M; Page C; Forbes B
Pulm Pharmacol Ther; 2020 Aug; 63():101943. PubMed ID: 32889156
[TBL] [Abstract][Full Text] [Related]
11. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
12. Role of purinergic system in tracheobronchial reactivity of healthy and bronchopathic subjects.
Susanna V; Loffreda A; Matera MG; Servodio R; Filippelli A; Santagata A; Montanaro C; Carapella N; Marmo E
Int J Tissue React; 1990; 12(1):59-65. PubMed ID: 2384299
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the anti-bronchoconstrictor activities of inhaled formoterol, its (R,R)- and (S,S)-enantiomers and salmeterol in the rhesus monkey.
Fozard JR; Buescher H
Pulm Pharmacol Ther; 2001; 14(4):289-95. PubMed ID: 11440557
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the novel potassium channel activator BRL 55834 as an inhaled bronchodilator in guinea-pigs and rats: comparison with levcromakalim and salbutamol.
Arch JR; Bowring NE; Buckle DR
Pulm Pharmacol; 1994 Apr; 7(2):121-8. PubMed ID: 8081072
[TBL] [Abstract][Full Text] [Related]
15. Specific antagonism of adenosine-induced bronchoconstriction in asthma by oral theophylline.
Mann JS; Holgate ST
Br J Clin Pharmacol; 1985 May; 19(5):685-92. PubMed ID: 4005106
[TBL] [Abstract][Full Text] [Related]
16. Histamine dose-response relationships in normal and asthmatic subjects. The importance of starting airway caliber.
Chung KF; Morgan B; Keyes SJ; Snashall PD
Am Rev Respir Dis; 1982 Nov; 126(5):849-54. PubMed ID: 7149450
[TBL] [Abstract][Full Text] [Related]
17. Interactions between response to inhaled prostaglandin E2 and chronic beta-adrenergic agonist treatment.
Walters EH; Bevan M; Davies BH
Thorax; 1982 Jun; 37(6):430-7. PubMed ID: 7135277
[TBL] [Abstract][Full Text] [Related]
18. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
[TBL] [Abstract][Full Text] [Related]
19. Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.
Harvey JE; Tattersfield AE
Thorax; 1982 Apr; 37(4):280-7. PubMed ID: 7112457
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
Lipworth BJ; Clark DJ; Koch P; Arbeeny C
Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
